BRIEF published on 04/14/2026 at 07:05, 1 month 7 days ago PolyPeptide Group observe les spéculations du marché concernant une potentielle prise de contrôle Croissance Des Revenus Revue Stratégique Groupe Polypeptide Spéculation Du Marché Intérêt Pour La Prise De Contrôle
BRIEF published on 04/14/2026 at 07:05, 1 month 7 days ago PolyPeptide Group Observes Market Speculation Regarding Potential Takeover Revenue Growth Strategic Review PolyPeptide Group Market Speculation Takeover Interest
PRESS RELEASE published on 04/14/2026 at 07:00, 1 month 7 days ago PolyPeptide Group AG takes note of market rumors and speculation PolyPeptide Group AG acknowledges market rumors and speculation regarding potential takeover interest, conducting a review of strategic options in coordination with majority shareholder Draupnir Holding B.V Strategic Options PolyPeptide Group Shareholder Review Market Rumors Takeover Interest
BRIEF published on 04/08/2026 at 18:15, 1 month 13 days ago L'assemblée générale annuelle 2026 de PolyPeptide Group obtient un large consensus. Conseil D'administration Groupe Polypeptide Approbation De La Rémunération Assemblée Générale Annuelle 2026 États Financiers 2025
BRIEF published on 04/08/2026 at 18:15, 1 month 13 days ago PolyPeptide Group's AGM 2026 Yields Broad Approvals Board Of Directors PolyPeptide Group Compensation Approval AGM 2026 Financial Statements 2025
PRESS RELEASE published on 04/08/2026 at 18:10, 1 month 13 days ago PolyPeptide announces results of the annual General Meeting 2026 PolyPeptide Group AG announces successful results of the annual General Meeting 2026 where shareholders approved all proposals by a large majority Board Of Directors Shareholders Pharmaceutical PolyPeptide Group AGM 2026
BRIEF published on 03/19/2026 at 07:05, 2 months 2 days ago PolyPeptide élargit sa ligne de crédit pour renforcer sa structure financière Croissance Des Revenus Facilité De Crédit Flexibilité Financière Syndicat Bancaire Produits Pharmaceutiques Peptidiques
BRIEF published on 03/19/2026 at 07:05, 2 months 2 days ago PolyPeptide Expands Credit Facility to Enhance Financial Structure Revenue Growth Credit Facility Banking Syndicate Financial Flexibility Peptide Pharmaceuticals
PRESS RELEASE published on 03/19/2026 at 07:00, 2 months 2 days ago PolyPeptide strengthens financing structure through expansion of existing credit facility PolyPeptide Group AG strengthens financing structure by expanding existing credit facility to EUR 200 million, backed by UBS, ING Bank, Danske Bank, and Zürcher Kantonalbank Financing Credit Facility PolyPeptide UBS ING Bank
BRIEF published on 03/17/2026 at 07:05, 2 months 4 days ago PolyPeptide Announces 2026 Annual General Meeting Annual General Meeting Financial Statements Board Re-election PolyPeptide Group Compensation Approval
Published on 05/21/2026 at 23:00, 4 hours 18 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 4 hours 18 minutes ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 4 hours 18 minutes ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/21/2026 at 22:15, 5 hours 3 minutes ago Linear Announces Acquisition, Share Consolidation and Private Placement
Published on 05/22/2026 at 03:05, 12 minutes ago BAI Capital Announces First Close of New US$800 Million Fund, Continues to Back Asia Growth and Globalization Opportunities
Published on 05/22/2026 at 02:40, 37 minutes ago ESENTIA Completes US $2 Billion Investment-Grade Bond Offering, Achieving Simultaneous Triple-Agency Rating on Inaugural Corporate Bond
Published on 05/21/2026 at 21:45, 5 hours 32 minutes ago Rendeavour becomes the African Continental Free Trade Area's inaugural implementation partner for African industrialisation and trade infrastructure
Published on 05/21/2026 at 20:10, 7 hours 7 minutes ago Ernst Russ AG Divests MV 'EF Emira' and Raises Full-Year 2026 Guidance
Published on 05/21/2026 at 20:05, 7 hours 12 minutes ago EQS-Adhoc: Ernst Russ AG: Upward revision of the guidance for the financial year 2026
Published on 05/21/2026 at 17:45, 9 hours 33 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 9 hours 33 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 16:35, 10 hours 42 minutes ago 260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026
